| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,765,525 | 8 | 89 |
Sells | $184,800 | 1 | 11 |
| ADAR1 Capital Management, LLC | 10 percent owner | 8 | $1.77M | 0 | $0 | $1.77M |
| Simcere Zaiming, Inc. | Former 10% Owner | 0 | $0 | 1 | $184,800 | $-184,800 |
NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metastatic solid tumors. Additionally, NextCure is progressing NC410 through Phase I studies; this novel immunomedicine is engineered to counteract immune …
Over the last 12 months, insiders at NextCure, Inc. have bought $1.77M and sold $184,800 worth of NextCure, Inc. stock.
On average, over the past 5 years, insiders at NextCure, Inc. have bought $1.77M and sold $184,800 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ADAR1 Capital Management, LLC (10 percent owner) — $1.77M.
The last purchase of 3,553 shares for transaction amount of $18,104 was made by ADAR1 Capital Management, LLC (10 percent owner) on 2026‑10‑27.
| 2026-10-27 | ADAR1 Capital Management, LLC | 10 percent owner | 3,553 0.0692% | $5.10 | $18,104 | +10.41% | ||
| 2026-10-26 | ADAR1 Capital Management, LLC | 10 percent owner | 1,672 0.0303% | $5.03 | $8,418 | +16.94% | ||
| 2026-10-23 | ADAR1 Capital Management, LLC | 10 percent owner | 5,626 0.1028% | $4.83 | $27,170 | +18.67% | ||
| 2026-08-10 | Sale | Simcere Zaiming, Inc. | Former 10% Owner | 30,000 0.5088% | $6.16 | $184,800 | -8.70% | |
| 2026-07-31 | ADAR1 Capital Management, LLC | 10 percent owner | 36,303 0.827% | $4.94 | $179,375 | +47.46% | ||
| 2026-07-30 | ADAR1 Capital Management, LLC | 10 percent owner | 292,850 5.4822% | $4.93 | $1.44M | +21.07% | ||
| 2026-07-29 | ADAR1 Capital Management, LLC | 10 percent owner | 3,410 0.094% | $5.00 | $17,050 | +20.82% | ||
| 2026-07-28 | ADAR1 Capital Management, LLC | 10 percent owner | 6,400 0.1618% | $4.95 | $31,677 | +11.44% | ||
| 2026-07-27 | ADAR1 Capital Management, LLC | 10 percent owner | 7,798 0.2108% | $5.00 | $38,985 | +17.87% | ||
| 2019-11-15 | Sofinnova Venture Partners IX, L.P. | 10 percent owner | 150,000 0.9742% | $36.75 | $5.51M | -7.91% | ||
| 2019-05-13 | ORBIMED ADVISORS LLC | 700,000 4.0096% | $15.00 | $10.5M | +82.16% | |||
| 2019-05-13 | Khuong Chau Quang | director | 350,000 2.0048% | $15.00 | $5.25M | +82.16% | ||
| 2019-05-13 | Sofinnova Venture Partners IX, L.P. | 10 percent owner | 400,000 2.2912% | $15.00 | $6M | +82.16% | ||
| 2019-05-13 | SHANNON TIMOTHY M | director | 50,000 0.2864% | $15.00 | $750,000 | +82.16% | ||
| 2019-05-13 | CANAAN X L.P. | 10 percent owner | 50,000 0.2864% | $15.00 | $750,000 | +82.16% | ||
| 2019-05-13 | Xu Stella | director | 125,000 0.716% | $15.00 | $1.88M | +82.16% |
| ADAR1 Capital Management, LLC | 10 percent owner | 733270 16.0195% | $4.33M | 8 | 0 | |
| ORBIMED ADVISORS LLC | 2711013 59.2266% | $16.02M | 1 | 0 | ||
| Khuong Chau Quang | director | 2711013 59.2266% | $16.02M | 1 | 0 | |
| Sofinnova Venture Partners IX, L.P. | 10 percent owner | 2671856 58.3711% | $15.79M | 2 | 0 | <0.0001% |
| SHANNON TIMOTHY M | director | 2254442 49.252% | $13.32M | 1 | 0 | |
| CANAAN X L.P. | 10 percent owner | 2254442 49.252% | $13.32M | 1 | 0 | |
| Xu Stella | director | 1103570 24.1093% | $6.52M | 1 | 0 |
$2,542,362 | 111 | 11.81% | $36.83M | |
$156,891,025 | 80 | -24.91% | $36.3M | |
$6,204,522 | 45 | 1.91% | $36.5M | |
$931,435 | 28 | 16.31% | $24.8M | |
$121,435,814 | 28 | 12.32% | $33.53M |
| Increased Positions | 14 | +87.5% | 1M | +159.35% |
| Decreased Positions | 5 | -31.25% | 76,645 | -10.94% |
| New Positions | 9 | New | 1M | New |
| Sold Out Positions | 2 | Sold Out | 63,179 | Sold Out |
| Total Postitions | 25 | +56.25% | 2M | +148.41% |
| Sofinnova Investments, Inc. | $2,957.00 | 5.57% | 222,654 | +8 | +<0.01% | 2025-09-30 |
| Affinity Asset Advisors, Llc | $2,548.00 | 4.8% | 191,882 | +7 | +<0.01% | 2025-09-30 |
| Vanguard Group Inc | $903.00 | 1.7% | 67,983 | -4,682 | -6.44% | 2025-09-30 |
| Cable Car Capital, Lp | $839.00 | 1.58% | 63,178 | +2 | +<0.01% | 2025-09-30 |
| Acadian Asset Management Llc | $487.00 | 0.92% | 36,675 | -4,027 | -9.89% | 2025-09-30 |
| Blackrock, Inc. | $413.00 | 0.78% | 31,086 | -248 | -0.79% | 2025-09-30 |
| Renaissance Technologies Llc | $376.00 | 0.71% | 28,334 | -13,409 | -32.12% | 2025-09-30 |
| Cardiff Park Advisors, Llc | $290.00 | 0.55% | 21,833 | +<1 | +<0.01% | 2025-09-30 |
| Geode Capital Management, Llc | $259.00 | 0.49% | 19,521 | +380 | +1.99% | 2025-09-30 |
| Sio Capital Management, Llc | $145.00 | 0.27% | 10,940 | <1 | <0.01% | 2025-09-30 |